Evidence map›Paper›PMID 36703774›Full record

ArticleClinical case reports2023

Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease treated with monoclonal antibodies against COVID-19: A case report.

Christian Lechner, Thomas Zöggeler, Romuald Bellmann, Jürgen Brunner, Manuela Zlamy, Michael Schirmer

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christian LechnerDepartment of Pediatrics, Clinic I Medical University of Innsbruck Innsbruck Austria.ORCID https://orcid.org/0000-0002-2720-1019
Thomas ZöggelerDepartment of Pediatrics, Clinic I Medical University of Innsbruck Innsbruck Austria.ORCID https://orcid.org/0000-0002-4991-2364
Romuald BellmannDepartment of Internal Medicine, Clinic II Medical University of Innsbruck Innsbruck Austria.ORCID https://orcid.org/0000-0003-2861-3258
Jürgen BrunnerDepartment of Pediatrics, Clinic I Medical University of Innsbruck Innsbruck Austria.
Manuela ZlamyDepartment of Pediatrics, Clinic I Medical University of Innsbruck Innsbruck Austria.ORCID https://orcid.org/0000-0003-3822-933X
Michael SchirmerDepartment of Internal Medicine, Clinic II Medical University of Innsbruck Innsbruck Austria.ORCID https://orcid.org/0000-0001-9208-7809
Innsbruck Medical University · ATDanube Private University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common variable immunodeficiency (CVID) is the most prevalent primary immunodeficiency. We present a 22-year-old Caucasian woman with CVID and granulomatous lymphocytic interstitial lung disease who contracted COVID-19 and was successfully treated with sotrovimab and molnupiravir. This treatment may have contributed to the relatively mild disease course of COVID-19 in our patient.

Indexed as

COVID‐19CVIDGLILDmolnupiravirprimary immunodeficiencysotrovimab

Identifiers

PMID36703774
PMCPMC9871406
OpenAlexW4317886131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.